Clinical, echocardiographic and hemodynamic predictors of right heart failure after LVAD placement

Right ventricular failure (RVF) after left ventricular assist device (LVAD) implant is associated with increasing morbidity and mortality. The aim of this study was to identify the best predictors of RVF post LVAD-implant among biochemical, haemodynamic and echocardiographic parameters. From 2009 to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The International Journal of Cardiovascular Imaging 2022-03, Vol.38 (3), p.561-570
Hauptverfasser: Stricagnoli, M., Sciaccaluga, C., Mandoli, G. E., Rizzo, L., Sisti, N., Aboumarie, H. S., Benfari, G., Maritan, L., Tsioulpas, C., Bernazzali, S., Maccherini, M., Natali, B. M., Focardi, M., D’Ascenzi, F., Lisi, M., Valente, S., Mondillo, S., Cameli, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Right ventricular failure (RVF) after left ventricular assist device (LVAD) implant is associated with increasing morbidity and mortality. The aim of this study was to identify the best predictors of RVF post LVAD-implant among biochemical, haemodynamic and echocardiographic parameters. From 2009 to 2019, 38 patients who underwent LVAD implantation at our centre were prospectively enrolled. Preoperative clinical, laboratory, echocardiographic and haemodynamic parameters were reported. Overall, eight patients (21%) developed RVF over time, which revealed to be strongly related to overall mortality. Pulmonary artery pulsatility index (PAPi) resulted to be the most significant right heart catheterization index in discriminating RVF vs no RVF patients [(1.32 ± 0.26 vs. 3.95 ± 3.39 respectively) p = 0.0036]. Regarding transthoracic echocardiography, RVF was associated with reduced free wall right ventricular longitudinal strain (fw-RVLS) (− 7.9 ± 1.29 vs. − 16.14 ± 5.83) (p 
ISSN:1569-5794
1573-0743
1875-8312
DOI:10.1007/s10554-021-02433-7